Drugs / Synthetic human AG
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02440061 Comparator | May 2018 → Jun 2019 | type 2 diabetes mellitus | Jenny Tong, MD, MPH | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Synthetic human AG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02440061 ↗ |
| Known as | acyl ghrelin | “while either acyl ghrelin (AG) or saline (salt solution) is being infused through your vein on separate study days.” NCT02440061 ↗ |
| Route | Intravenous | “while either acyl ghrelin (AG) or saline (salt solution) is being infused through your vein on separate study days.” NCT02440061 ↗ |